Financhill
Back

ADMA Biologics Quote, Financials, Valuation and Earnings

ADMA Biologics Price Quote

$13.59
-0.17 (-1.24%)
(Updated: July 24, 2024 at 6:55 PM ET)

ADMA Biologics Key Stats

Buy
79
ADMA Biologics (ADMA) is a Buy

Day range:
$13.60 - $14.03
52-week range:
$3.06 - $14.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.06
P/B ratio:
20.75%

Volume:
2.8M
Avg. volume:
3.3M
1-year change:
260.21%
Market cap:
$3.2B
Revenue:
$258.2M
EPS:
$-0.02

How Much Does ADMA Biologics Make?

Is ADMA Biologics Growing As A Company?

  • What Is ADMA Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.44%
  • What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ADMA Biologics Stock Price Performance

  • Did ADMA Biologics Stock Go Up Last Month?
    ADMA Biologics share price went up by 25.09% last month
  • Did ADMA's Share Price Rise Over The Last Year?
    ADMA share price rose by 260.21% over the past 1 year

What Is ADMA Biologics 52-Week High & Low?

ADMA Biologics Price To Free Cash Flow

Is It Risky To Buy ADMA Biologics?

  • How Much Debt Does ADMA Biologics Have?
    Total long term debt quarterly is $130.8M
  • How Much Cash Does ADMA Biologics Have?
    Cash and short term investments quarterly total is $45.3M
  • What Is ADMA Biologics’s Book Value Per Share?
    Book value per share is 0.66

Is ADMA Biologics Cash Flow Positive?

  • What Is ADMA Cash Flow From Operations?
    Cash flow from operations (TTM) is $21.3M
  • What Is ADMA Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$39.8M
  • What Is ADMA Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.4M

ADMA Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADMA return on invested capital is -1.28%
  • What Is ADMA Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is -1.06%
  • What Is ADMA Return On Equity?
    ROE is a measure of profitability and is -2.49%

ADMA Biologics Earnings Date & Stock Price

ADMA Biologics Competitors

  • Who Are ADMA Biologics's Competitors?
    Below is a list of companies who compete with ADMA Biologics or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Corcept Therapeutics Inc (CORT)
    • Keros Therapeutics Inc (KROS)
    • Krystal Biotech Inc (KRYS)
    • Sarepta Therapeutics Inc (SRPT)

ADMA Biologics Dividend Yield

Data Unavailable

ADMA Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 60%
Revenue: 43.86% 5.95%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.75
Downside from Last Price: -0.07%

Major Shareholders

  • How many ADMA shares are owned by institutional investors?
    269.7M ADMA shares are owned by institutional investors
  • How many ADMA shares are owned by insiders?
    5M ADMA shares are owned by insiders